With expertise that spans basic, translational and clinical research, Brigham and Women’s Hospital clinicians and investigators are working tirelessly to address the most urgent needs related to the COVID-19 pandemic.
To help reduce the spread of COVID-19, the Brigham has shut down most of its physical research labs. But many labs are still performing COVID-19 research remotely to better understand SARS-CoV-2 and COVID-19 in order to develop treatment strategies against them. Read More
Last fall, Ellen M. Gravallese, MD, was named chief of the Division of Rheumatology, Inflammation and Immunity at Brigham and Women’s Hospital and president of the American College of Rheumatology (ACR). In these roles, she is overseeing the response of the division and the ACR to the alarming spread of the novel coronavirus.
“The ACR has taken a very proactive stance to try to address COVID-19,” Dr. Gravallese said. “We understand how difficult this pandemic has been for rheumatologists in caring and making the best decisions for their patients while at the same time limiting community exposure to the SARS-CoV-2 virus as much as possible. We hope the work we are doing at the ACR will provide immediate assistance to physicians in these efforts.” Read More